<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; NPPP2011</title>
	<atom:link href="http://www.tapanray.in/tag/nppp2011/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>The New Drug Policy of India enters into the final lap of a Marathon Run</title>
		<link>http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run</link>
		<comments>http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/#comments</comments>
		<pubDate>Mon, 21 May 2012 00:00:54 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[DPCO]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[enters]]></category>
		<category><![CDATA[final]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[into]]></category>
		<category><![CDATA[lap]]></category>
		<category><![CDATA[Marathon]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NLEM2011]]></category>
		<category><![CDATA[NPPP2011]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Run]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=91</guid>
		<description><![CDATA[Final working out and thereafter announcement of much awaited and long overdue the new ‘Drug Policy’ of India has now entered into a very interesting stage. This is mainly because of the unique combination of the following three key reasons: &#8230; <a href="http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Draft National Pharmaceutical Pricing Policy 2011: A flawed recipe</title>
		<link>http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe</link>
		<comments>http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 00:00:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2011]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[Draft]]></category>
		<category><![CDATA[flawed]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[NPPP2011]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[recipe]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=168</guid>
		<description><![CDATA[The ‘Drug Price’ has always remained one of the critical factors to ensure greater access to medicines, especially in the developing economies like India, where predominantly individuals are the payers. This point has also been widely accepted by the international &#8230; <a href="http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/draft-national-pharmaceutical-pricing-policy-2011-a-flawed-recipe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
